Skip to content

Clinical trials

Phase 1 Ovarian Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1 Country / region: Germany Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20112
20131
20141
20163
20171
20201
20222
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting4
Terminated3
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Eli Lilly and Company2
Array Biopharma, now a wholly owned subsidiary of Pfizer1
AstraZeneca1
BioNTech Cell & Gene Therapies GmbH1
Boehringer Ingelheim1
Clemens Tempfer1
EMD Serono Research & Development Institute, Inc.1
Exelixis1
Ganymed Pharmaceuticals GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms17
Carcinoma, Non-Small-Cell Lung7
Colorectal Neoplasms5
Endometrial Neoplasms5
Melanoma5
Breast Neoplasms4
Cholangiocarcinoma4
Esophageal Neoplasms4
Neoplasms4
Stomach Neoplasms4

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.